INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹261 Cr | ₹157 Cr | ₹158 Cr | ₹101 Cr | ₹116 Cr |
What is the latest Total Non-Current Liabilities ratio of INDOCO REMEDIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹261 Cr |
Mar2022 | ₹157 Cr |
Mar2021 | ₹158 Cr |
Mar2020 | ₹101 Cr |
Mar2019 | ₹116 Cr |
How is Total Non-Current Liabilities of INDOCO REMEDIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹261 Cr | 66.63 | |
Mar2022 | ₹157 Cr | -1.12 | |
Mar2021 | ₹158 Cr | 56.80 | |
Mar2020 | ₹101 Cr | -13.24 | |
Mar2019 | ₹116 Cr | - |
Compare Total Non-Current Liabilities of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹3,029.2 Cr | 0.2% | -2% | 4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | 0.2% |
-2% |
4% |
SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses